Shigella-mediated immunosuppression in the human gut: subversion extends from innate to adaptive immune responses

References

• Marteyn BS. Shigella vaccine development : the model matters. JSM Trop Med Res. 2016;1:1011–14.
   Google Scholar
• Banish LD, Sims R, Sack D, Montali RJ, Phillips L, Bush M. Prevalence of shigellosis and other enteric pathogens in a zoologic collection of primates. J Am Vet Med Assoc. 1993;203:126–32.
   PubMed Web of Science ®Google Scholar
• Black-Schultz L, Coatney RW, Warnick CL, Swif B. Lack of reactivation of shigellosis in naturally infected enrofloxacin-treated cynomolgus monkeys after exogenous immunosuppression. Lab Anim Sci. 1997;47:602–05.
   PubMedGoogle Scholar
• Vickers JH. Infectious diseases of primates related to capture and transportation. Am J Phys Anthropol. 1973;38:511–13. doi:https://doi.org/10.1002/(ISSN)1096-8644.
   PubMed Web of Science ®Google Scholar
• Collins TA, Barnoy S, Baqar S, Ranallo RT, Nemelka KW, Venkatesan MM. Safety and colonization of two novel virG(icsA)-based live Shigella sonnei vaccine strains in Rhesus macaques (Macaca mulatta). Comp Med. 2008;58:88–94.
   PubMed Web of Science ®Google Scholar
• Dupont HL, Levine MM, Hornick RB, Formal SB. Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis. 1989;159:1126–28.
   PubMed Web of Science ®Google Scholar
• Islam MS, Hasan MK, Khan SI. Growth and survival of Shigella flexneri in common bangladeshi foods under various conditions of time and temperature. Appl Environ Microbiol. 1993;59:652–54.
   PubMed Web of Science ®Google Scholar
• Mestas J, Hughes CCW. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;175:2731–38. doi:https://doi.org/10.4049/jimmunol.172.5.2731.
   Web of Science ®Google Scholar
• Gorden J, Small PLC. Acid resistance in enteric bacteria. Infect Immun. 1993;61:364–67.
   PubMed Web of Science ®Google Scholar
• Kararli TT. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos. 1995;16:351–80. doi:https://doi.org/10.1002/(ISSN)1099-081X.
   PubMed Web of Science ®Google Scholar
• Nickerson KP, Chanin RB, Sistrunk JR, Rasko DA, Fink PJ, Barry EM, Nataro JP, Faherty CS. Analysis of Shigella flexneri resistance, biofilm formation, and transcriptional profile in response to bile salts. Infect Immun. 2017;85:e01067–16. doi:https://doi.org/10.1128/IAI.01067-16.
   PubMed Web of Science ®Google Scholar
• Lagkouvardos I, Pukall R, Abt B, Foesel BU, Meier-Kolthoff JP, Kumar N, Bresciani A, Martínez I, Just S, Ziegler C, et al. The Mouse Intestinal Bacterial Collection (miBC) provides host-specific insight into cultured diversity and functional potential of the gut microbiota. Nat Microbiol. 2016;1:16131. doi:https://doi.org/10.1038/nmicrobiol.2016.131.
   PubMed Web of Science ®Google Scholar
• Spor A, Koren O, Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol. 2011;9:279–90. doi:https://doi.org/10.1038/nrmicro2540.
   PubMed Web of Science ®Google Scholar
• Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol. 2014;14:667–85. doi:https://doi.org/10.1038/nri3738.
   PubMed Web of Science ®Google Scholar
• McGuckin MA, Lindén SK, Sutton P, Florin TH. Mucin dynamics and enteric pathogens. Nat Rev Microbiol. 2011;9:265–78. doi:https://doi.org/10.1038/nrmicro2538.
   PubMed Web of Science ®Google Scholar
• Sai Sudha P, Devaraj H, Devaraj N. Adherence of Shigella dysenteriae 1 to human colonic mucin. Curr Microbiol. 2001;42:381–87. doi:https://doi.org/10.1007/s002840010234.
   PubMed Web of Science ®Google Scholar
• Prakash R, Raja S, Devaraj H, Devaraj SN. Up-regulation of MUC2 and IL-1β expression in human colonic epithelial cells by Shigella and its interaction with mucins. PLoS One. 2011;6:e27046. doi:https://doi.org/10.1371/journal.pone.0027046.
   PubMed Web of Science ®Google Scholar
• Patil A, Hughes AL, Zhang G. Rapid evolution and diversification of mammalian α-defensins as revealed by comparative analysis of rodent and primate genes. Physiol Genomics. 2004;20:1–11. doi:https://doi.org/10.1152/physiolgenomics.00150.2004.
   PubMed Web of Science ®Google Scholar
• Bals R, Lang C, Weiner DJ, Vogelmeier C, Welsch U, Wilson JM. Rhesus monkey (Macaca mulatta) mucosal antimicrobial peptides are close homologues of human molecules. Clin Diagnostic Lab Immunol. 2001;8:370–75.
   PubMedGoogle Scholar
• Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, Agerberth B, Gudmundsson GH. Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med. 2001;7:180–85. doi:https://doi.org/10.1038/84627.
   PubMed Web of Science ®Google Scholar
• Sperandio B, Regnault B, Guo J, Zhang Z, Stanley SL, Sansonetti PJ, Pédron T. Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression. J Exp Med. 2008;205:1121–32. doi:https://doi.org/10.1084/jem.20071698.
   PubMed Web of Science ®Google Scholar
• Singer M, Sansonetti PJ. IL-8 is a key chemokine regulating neutrophil recruitment in a new mouse model of Shigella-induced colitis. J Immunol. 2004;173:4197–206. doi:https://doi.org/10.4049/jimmunol.173.6.4197.
   PubMed Web of Science ®Google Scholar
• Perdomo JJ, Gounon P, Sansonetti PJ. Polymorphonuclear leukocyte transmigration promotes invasion of colonic epithelial monolayer by Shigella flexneri. J Clin Invest. 1994;93:633–43. doi:https://doi.org/10.1172/JCI117015.
   PubMed Web of Science ®Google Scholar
• Sansonetti PJ, Arondel J, Cavaillon JM, Huerre M. Role of interleukin-1 in the pathogenesis of experimental shigellosis. J Clin Invest. 1995;96:884–92. doi:https://doi.org/10.1172/JCI118135.
   PubMed Web of Science ®Google Scholar
• Sansonetti PJ, Arondel J, Huerre M, Harada A, Matsushima K. Interleukin-8 controls bacterial transepithelial translocation at the cost of epithelial destruction in experimental shigellosis. Infect Immun. 1999;67:1471–80.
   PubMed Web of Science ®Google Scholar
• Shim D-H, Suzuki T, Chang S-Y, Park S-M, Sansonetti PJ, Sasakawa C, Kweon M-N. New animal model of shigellosis in the guinea pig: its usefulness for protective efficacy studies. J Immunol. 2007;178:2476–82. doi:https://doi.org/10.4049/jimmunol.178.4.2476.
   PubMed Web of Science ®Google Scholar
• Voino-Yasenetsky MV, Voino-Yasenetskaya MK. Experimental pneunomia caused by bacteria of the Shigella group. Acta Morphol Acad Sci Hung. 1962;11:439–54.
   PubMedGoogle Scholar
• Phalipon A, Kaufmann M, Michetti P, Cavaillon J-M, Huerre M, Sansonetti PJ, Kraehenbuhlll J-P. Monoclonal immunoglobulin a antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J Exp Med. 1995;182:769–78. doi:https://doi.org/10.1084/jem.182.3.769.
   PubMed Web of Science ®Google Scholar
• Galán JE, Waksman G. Protein-injection machines in bacteria. Cell. 2018;172:P1306–1318. doi:https://doi.org/10.1016/j.cell.2018.01.034.
   PubMed Web of Science ®Google Scholar
• de Nisco NJ, Rivera-Cancel G, Orth K. The biochemistry of sensing: enteric pathogens regulate type III secretion in response to environmental and host cues. MBio. 2018;9:e02122–17. doi:https://doi.org/10.1128/mBio.02122-17.
   PubMed Web of Science ®Google Scholar
• Gunasinghe SD, Webb CT, Elgass KD, Hay ID, Lithgow T. Super-resolution imaging of protein secretion systems and the cell surface of gram-negative bacteria. Front Cell Infect Microbiol. 2017;7:220. doi:https://doi.org/10.3389/fcimb.2017.00517.
   PubMed Web of Science ®Google Scholar
• Sansonetti PJ, Kopecko DJ, Formal SB. Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect Immun. 1982;35:852–60.
   PubMed Web of Science ®Google Scholar
• Galán JE, Lara-Tejero M, Marlovits TC, Wagner S. Bacterial type III secretion systems: specialized nanomachines for protein delivery into target cells. Annu Rev Microbiol. 2014;68:415–38. doi:https://doi.org/10.1146/annurev-micro-092412-155725.
   PubMed Web of Science ®Google Scholar
• Maurelli AT, Blackmon B, Curtis R III. Temperature-Dependent Expression of virulence genes in Shigella species. Infect Immun. 1984;43:195–201.
   PubMed Web of Science ®Google Scholar
• Veenendaal AKJ, Hodgkinson JL, Schwarzer L, Stabat D, Zenk SF, Blocker AJ. The type III secretion system needle tip complex mediates host cell sensing and translocon insertion. Mol Microbiol. 2007;63:1719–30. doi:https://doi.org/10.1111/j.1365-2958.2006.05509.x.
   PubMed Web of Science ®Google Scholar
• Ménard R, Sansonetti PJ, Parsot C. The secretion of the Shigella flexneri Ipa invasins is activated by epithelial cells and controlled by IpaB and IpaD. Embo J. 1994;13:5293–302. doi:https://doi.org/10.1002/j.1460-2075.1994.tb06863.x.
   PubMed Web of Science ®Google Scholar
• Enninga J, Mounier J, Sansonetti P. Tran Van Nhieu G. Secretion of type III effectors into host cells in real time. Nat Methods. 2005;2:959–65. doi:https://doi.org/10.1038/nmeth738.
   PubMed Web of Science ®Google Scholar
• Marlovits TC, Kubori T, Sukhan A, Galán JE, Unger VM. Structural insights into the assembly of the type III secretion needle complex. Science. 2004;306:1040–42. doi:https://doi.org/10.1126/science.1102610.
   PubMed Web of Science ®Google Scholar
• Martinez-Argudo I, Blocker AJ. The Shigella T3SS needle transmits a signal for MxiC release, which controls secretion of effectors. Mol Microbiol. 2010;78:1365–78. doi:https://doi.org/10.1111/j.1365-2958.2010.07413.x.
   PubMed Web of Science ®Google Scholar
• Demers B, Sansonetti PJ, Parsot C. Induction of type III secretion in Shigella flexneri is associated with differential control of transcription of genes encoding secreted proteins. Embo J. 1998;17:2894–903. doi:https://doi.org/10.1093/emboj/17.11.3016.
   PubMed Web of Science ®Google Scholar
• Campbell-Valois FX, Schnupf P, Nigro G, Sachse M, Sansonetti PJ, Parsot C. A fluorescent reporter reveals on/off regulation of the Shigella type III secretion apparatus during entry and cell-to-cell spread. Cell Host Microbe. 2014;15:177–89. doi:https://doi.org/10.1016/j.chom.2014.01.005.
   PubMed Web of Science ®Google Scholar
• Page AL, Ohayon H, Sansonetti PJ, Parsot C. The secreted IpaB and IpaC invasins and their cytoplasmic chaperone IpgC are required for intercellular dissemination of Shigella flexneri. Cell Microbiol. 1999;1:183–93.
   PubMed Web of Science ®Google Scholar
• Schuch R, Sandlin RC, Maurelli AT. A system for identifying post-invasion functions of invasion genes: requirements for the Mxi-Spa type III secretion pathway of Shigella flexneri in intercellular dissemination. Mol Microbiol. 1999;34:675–89. doi:https://doi.org/10.1046/j.1365-2958.1999.01627.x.
   PubMed Web of Science ®Google Scholar
• Pinaud L, Sansonetti PJ, Phalipon A. Host cell targeting by enteropathogenic bacteria T3SS effectors. Trends Microbiol. 2018;26:266–83. doi:https://doi.org/10.1016/j.tim.2018.01.010.
   PubMed Web of Science ®Google Scholar
• de Jong MF, Alto NM. Cooperative immune suppression by Escherichia coli and Shigella effector proteins. Infect Immun. 2018;86:e00560–17. doi:https://doi.org/10.1128/IAI.00560-17.
   PubMed Web of Science ®Google Scholar
• Ashida H, Mimuro H, Sasakawa C. Shigella manipulates host immune responses by delivering effector proteins with specific roles. Front Immunol. 2015;6:219. doi:https://doi.org/10.3389/fimmu.2015.00219.
   PubMed Web of Science ®Google Scholar
• Jain S, Sharma M, Gupta R, Shree N, Kumar M. Multidrug resistant Shigella flexneri: A rare case of septicemia in an infant. J Clin Diagnostic Res. 2014;8:DD03–DD04.
   PubMedGoogle Scholar
• Islam D, Wretlind B, Hammarström L, Christensson B, Lindberg AA. Semiquantitative estimation of Shigella antigen-specific antibodies: correlation with disease severity during shigellosis. Apmis. 1996;104:563–74. doi:https://doi.org/10.1111/j.1699-0463.1996.tb04912.x.
   PubMed Web of Science ®Google Scholar
• Islam D, Veress B, Bardhan PK, Lindberg AA, Christensson B. In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis. In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis. Infect Immun. 1997;65:739–49.
   PubMed Web of Science ®Google Scholar
• Barry EM, Pasetti MF, Sztein MB, Fasano A, Kotloff KL, Levine MM. Progress and pitfalls in Shigella vaccine research. Nat Rev Gastroenterol Hepatol. 2013;10:245–55. doi:https://doi.org/10.1038/nrgastro.2013.12.
   PubMed Web of Science ®Google Scholar
• Formal SB, Oaks EV, Olsen RE, Wingfield-Eggleston M, Snoy PJ, Cogan JP. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei. J Infect Dis. 1991;164:533–37. doi:https://doi.org/10.1093/infdis/164.3.533.
   PubMed Web of Science ®Google Scholar
• Wahid R, Simon JK, Picking WL, Kotloff KL, Levine MM, Sztein MB. Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a. Clin Immunol. 2013;148:35–43. doi:https://doi.org/10.1016/j.clim.2013.03.009.
   PubMed Web of Science ®Google Scholar
• Dupont HL, Hornick RB, Snyder MJ, Libonati JP, Formal SB, Gangarosa EJ. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. J Infect Dis. 1972;125:12–16. doi:https://doi.org/10.1093/infdis/125.1.12.
   PubMed Web of Science ®Google Scholar
• Raqib R, Qadri F, Sarker P, Mia SMS, Sansonnetti PJ, Albert MJ, Andersson J. Delayed and reduced adaptive humoral immune responses in children with shigellosis compared with in adults. Scand J Immunol. 2002;55:414–23. doi:https://doi.org/10.1046/j.1365-3083.2002.01079.x.
   PubMed Web of Science ®Google Scholar
• Raqib R, Ekberg C, Sharkar P, Bardhan PK, Zychlinsky A, Sansonetti PJ, Andersson J. Apoptosis in acute shigellosis is associated with increased production of fas/fas ligand, perforin, caspase-1, and caspase-3 but reduced production of Bcl-2 and interleukin-2. Infect Immun. 2002;70:3199–207. doi:https://doi.org/10.1128/IAI.70.6.3199-3207.2002.
   PubMed Web of Science ®Google Scholar
• Raqib R, Mia SMS, Qadri F, Alam TI, Alam NH, Chowdhury AK, Mathan MM, Andersson J. Innate immune responses in children and adults with shigellosis. Infect Immun. 2000;68:3620–29. doi:https://doi.org/10.1128/IAI.68.6.3620-3629.2000.
   PubMed Web of Science ®Google Scholar
• Pédron T, Thibault C, Sansonetti PJ. The invasive phenotype of Shigella flexneri directs a distinct gene expression pattern in the human intestinal epithelial cell line Caco-2. J Biol Chem. 2003;278:33878–86. doi:https://doi.org/10.1074/jbc.M303749200.
   PubMed Web of Science ®Google Scholar
• Edgeworth JD, Spencer J, Phalipon A, Griffin GE, Sansonetti PJ. Cytotoxicity and interleukin-1β processing following Shigella flexneri infection of human monocyte-derived dendritic cells. Eur J Immunol. 2002;32:1464–71. doi:https://doi.org/10.1002/1521-4141(200205)32:5<1464::AID-IMMU1464>3.0.CO;2-G.
   PubMed Web of Science ®Google Scholar
• Sellge G, Magalhaes JG, Konradt C, Fritz JH, Salgado-Pabon W, Eberl G, Bandeira A, Di Santo JP, Sansonetti PJ, Phalipon A. Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity. J Immunol. 2010;184:2076–85. doi:https://doi.org/10.4049/jimmunol.0902016.
   PubMed Web of Science ®Google Scholar
• Raqib R, Lindberg AA, Wretlind B, Bardhan PK, Andersson U, Andersson J. Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect Immun. 1995;63:289–96.
   PubMed Web of Science ®Google Scholar
• Raqib R, Lindberg AA, Bjork L, Bardhan PK, Wretlind B, Andersson U, Andersson J. Down-regulation of gamma interferon, tumor necrosis factor type I, interleukin 1 (IL-1) type I, IL-3, IL-4, and transforming growth factor beta type I receptors at the local site during the acute phase of Shigella infection. Infect Immun. 1995;63:3079–87.
   PubMed Web of Science ®Google Scholar
• Curtis MM, Way SS. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology. 2009;126:177–85. doi:https://doi.org/10.1111/imm.2008.126.issue-2.
   PubMed Web of Science ®Google Scholar
• Zhou L, Chong MMW, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity. 2009;30:646–55. doi:https://doi.org/10.1016/j.immuni.2009.05.001.
   PubMed Web of Science ®Google Scholar
• Jehl SP, Doling AM, Giddings KS, Phalipon A, Sansonetti PJ, Goldberg MB, Starnbach MN. Antigen-specific CD8+ T cells fail to respond to Shigella flexneri. Infect Immun. 2011;79:2021–30. doi:https://doi.org/10.1128/IAI.00040-11.
   PubMed Web of Science ®Google Scholar
• Pinaud L, Samassa F, Porat Z, Ferrari ML, Belotserkovsky I, Parsot C, Sansonetti PJ, Campbell-Valois F-X, Phalipon A. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes. Proc Natl Acad Sci. 2017;114:9954–59. doi:https://doi.org/10.1073/pnas.1707098114.
   PubMed Web of Science ®Google Scholar
• Nothelfer K, Arena ET, Pinaud L, Neunlist M, Mozeleski B, Belotserkovsky I, Parsot C, Dinadayala P, Burger-Kentischer A, Raqib R, et al. B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection. J Exp Med. 2014;211:1215–29. doi:https://doi.org/10.1084/jem.20130914.
   PubMed Web of Science ®Google Scholar
• Belotserkovsky I, Brunner K, Pinaud L, Rouvinski A, Dellarole M, Baron B, Dubey G, Samassa F, Parsot C, Sansonetti P, et al. Glycan-glycan interaction determines Shigella tropism toward human T lymphocytes. MBio. 2018;9:e02309–17. doi:https://doi.org/10.1128/mBio.02309-17.
   PubMed Web of Science ®Google Scholar
• Shanker S, Hu L, Ramani S, Atmar RL, Estes MK. Venkataram Prasad B V. Structural features of glycan recognition among viral pathogens. Curr Opin Struct Biol. 2017;44:211–18. doi:https://doi.org/10.1016/j.sbi.2017.05.007.
   PubMed Web of Science ®Google Scholar
• Xu D, Liao C, Zhang B, Tolbert WD, He W, Dai Z, Zhang W, Yuan W, Pazgier M, Liu J, et al. Human enteric α-defensin 5 promotes Shigella Infection by enhancing bacterial adhesion and invasion. Immunity. 2018;48:1233–43. doi:https://doi.org/10.1016/j.immuni.2018.04.005.
   PubMed Web of Science ®Google Scholar
• Faherty CS, Redman JC, Rasko DA, Barry EM, Nataro JP. Shigella flexneri effectors OspE1 and OspE2 mediate induced adherence to the colonic epithelium following bile salts exposure. Mol Microbiol. 2012;85:107–21. doi:https://doi.org/10.1111/j.1365-2958.2012.08092.x.
   PubMed Web of Science ®Google Scholar
• Brotcke Zumsteg A, Goosmann C, Brinkmann V, Morona R, Zychlinsky A. IcsA is a Shigella flexneri adhesion regulated by the type III secretion system and required for pathogenesis. Cell Host Microbe. 2014;15:435–45. doi:https://doi.org/10.1016/j.chom.2014.03.001.
   PubMed Web of Science ®Google Scholar
• Baum LG, Crocker PR. Glycoimmunology: ignore at your peril!. Immunol Rev. 2009;230:5–8.
   Google Scholar
• Konradt C, Frigimelica E, Nothelfer K, Puhar A, Salgado-Pabon W, Bartolo V, Scott-Algara D, Rodrigues CD, Sansonetti PJ, Phalipon A. The Shigella flexneri type three secretion system effector IpgD inhibits T cell migration by manipulating host phosphoinositide metabolism. Cell Host Microbe. 2011;9:263–72. doi:https://doi.org/10.1016/j.chom.2011.03.010.
   PubMed Web of Science ®Google Scholar
• Salgado-Pabon W, Celli S, Arena ET, Nothelfer K, Roux P, Sellge G, Frigimelica E, Bousso P, Sansonetti PJ, Phalipon A. Shigella impairs T lymphocyte dynamics in vivo. Proc Natl Acad Sci. 2013;110:4458–63. doi:https://doi.org/10.1073/pnas.1300981110.
   PubMed Web of Science ®Google Scholar
• Toapanta FR, Bernal PJ, Fresnay S, Magder LS, Darton TC, Jones C, Waddington CS, Blohmke CJ, Angus B, Levine MM, et al. Oral challenge with wild-type Salmonella typhi induces distinct changes in B cell subsets in individuals who develop typhoid disease. PLoS Negl Trop Dis. 2016;10:e0004766. doi:https://doi.org/10.1371/journal.pntd.0004766.
   PubMed Web of Science ®Google Scholar
• Fresnay S, McArthur MA, Magder L, Darton TC, Jones C, Waddington CS, Blohmke CJ, Angus B, Levine MM, Pollard AJ, et al. Salmonella typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans. J Transl Med. 2016;14:62. doi:https://doi.org/10.1186/s12967-016-0867-z.
   PubMed Web of Science ®Google Scholar
• Juel HB, Thomaides-Brears HB, Darton TC, Jones C, Jones E, Shrestha S, Sie R, Eustace A, Galal U, Kurupati P, et al. Salmonella typhi bactericidal antibodies reduce disease severity but do not protect against typhoid fever in a controlled human infection model. Front Immunol. 2018;8:1916. doi:https://doi.org/10.3389/fimmu.2017.01960.
   PubMed Web of Science ®Google Scholar
• Porter CK, Louis Bourgeois A, Frenck RW, Prouty M, Maier N, Riddle MS. Developing and utilizing controlled human models of infection. Vaccine. 2017;35:6813–18. doi:https://doi.org/10.1016/j.vaccine.2017.05.068.
   PubMed Web of Science ®Google Scholar
• Porter CK, Lynen A, Riddle MS, Talaat K, Sack D, Gutiérrez RL, McKenzie R, DeNearing B, Feijoo B, Kaminski RW, et al. Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score. PLoS One. 2018;13:e0194325. doi:https://doi.org/10.1371/journal.pone.0194325.
   PubMed Web of Science ®Google Scholar
• Gebhardt T, Mackay LK. Local immunity by tissue-resident CD8+ memory T cells. Front Immunol. 2012;3:340. doi:https://doi.org/10.3389/fimmu.2012.00198.
   PubMed Web of Science ®Google Scholar
• Sathaliyawala T, Kubota M, Yudanin N, Turner D, Camp P, Thome JJC, Bickham KL, Lerner H, Goldstein M, Sykes M, et al. Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity. 2013;38:187–97. doi:https://doi.org/10.1016/j.immuni.2012.09.020.
   PubMed Web of Science ®Google Scholar
• Bergsbaken T, Bevan MJ, Fink PJ. Local inflammatory cues regulate differentiation and persistence of CD8+ tissue-resident memory T cells. Cell Rep. 2017;19:114–24. doi:https://doi.org/10.1016/j.celrep.2017.03.031.
   PubMed Web of Science ®Google Scholar
• Kentner D, Martano G, Callon M, Chiquet P, Brodmann M, Burton O. Shigella reroutes host cell central metabolism to obtain high-flux nutrient supply for vigorous intracellular growth. Proc Natl Acad Sci USA. 2014;111:9929–34.
   Google Scholar
• Buck MDD, O’Sullivan D, Klein Geltink RII, Curtis JDD, Chang CH, Sanin DEE, Qiu J, Kretz O, Braas D, van der Windt GJJW, et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell. 2016;166:63–76. doi:https://doi.org/10.1016/j.cell.2016.05.035.
   PubMed Web of Science ®Google Scholar
• Mani S, Wierzba T, Walker RI. Status of vaccine research and development for Shigella. Vaccine. 2016;34:2887–94. doi:https://doi.org/10.1016/j.vaccine.2016.10.045.
   PubMed Web of Science ®Google Scholar
• Coster TS, Hoge CW, VanDeVerg LL, Hartman AB, Oaks EV, Venkatesan MM, Cohen D, Robin G, Fontaine-Thompson A, Sansonetti PJ, et al. Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602. Infect Immun. 1999;67:3437–43.
   PubMed Web of Science ®Google Scholar
• Rahman KM, Arifeen SE, Zaman K, Rahman M, Raqib R, Yunus M, Begum N, Islam MS, Sohel BM, Rahman M, et al. Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh. Vaccine. 2011;29:1347–54. doi:https://doi.org/10.1016/j.vaccine.2010.10.035.
   PubMed Web of Science ®Google Scholar
• Passwell JH, Ashkenzi S, Banet-Levi Y, Ramon-Saraf R, Farzam N, Lerner-Geva L, Even-Nir H, Yerushalmi B, Chu C, Shiloach J, et al. Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children. Vaccine. 2010;28:2231–35. doi:https://doi.org/10.1016/j.vaccine.2009.12.050.
   PubMed Web of Science ®Google Scholar
• Riddle MS, Kaminski RW, Di Paolo C, Porter CK, Gutierrez RL, Clarkson KA, Weerts HE, Duplessis C, Castellano A, Alaimo C, et al. Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella flexneri 2a administered to healthy adults: A single-blind, randomized phase i study. Clin Vaccine Immunol. 2016;23:908–17. doi:https://doi.org/10.1128/CVI.00224-16.
   PubMed Web of Science ®Google Scholar
• Hatz CFR, Bally B, Rohrer S, Steffen R, Kramme S, Siegrist CA, Wacker M, Alaimo C, Fonck VG. Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study. Vaccine. 2015;33:4594–601. doi:https://doi.org/10.1016/j.vaccine.2015.06.102.
   PubMed Web of Science ®Google Scholar
• Phalipon A, Tanguy M, Grandjean C, Guerreiro C, Belot F, Cohen D, Sansonetti PJ, Mulard LA. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection. J Immunol. 2009;182:2241–47. doi:https://doi.org/10.4049/jimmunol.0802775.
   PubMed Web of Science ®Google Scholar
• Launay O, Lewis DJM, Anemona A, Loulergue P, Leahy J, Sciré AS, Maugard A, Marchetti E, Zancan S, Huo Z, et al. Safety profile and immunologic responses of a novel vaccine against Shigella sonnei administered intramuscularly, intradermally and intranasally: results from two parallel randomized phase 1 clinical studies in healthy adult volunteers in Europe. EBio Med. 2017;22:164–72. doi:https://doi.org/10.1016/j.ebiom.2017.07.013.
   PubMed Web of Science ®Google Scholar
• Gerke C, Colucci AM, Giannelli C, Sanzone S, Vitali CG, Sollai L, Rossi O, Martin LB, Auerbach J, Di Cioccio V, et al. Production of a Shigella sonnei vaccine based on generalized modules for membrane antigens (GMMA), 1790GAHB. PLoS One. 2015;10:e0134478. doi:https://doi.org/10.1371/journal.pone.0134478.
   PubMed Web of Science ®Google Scholar
• Bill & Melinda Gates Foundation. Enteric and diarrheal diseases strategy overview [Internet]; [accessed 2018 Dec 10]. https://www.gatesfoundation.org/What-We-Do/Global-Health/Enteric-and-Diarrheal-Diseases.
   Google Scholar
• Global Biodefences. Wellcome trust to finance development of Shigella vaccine [Internet]. [accessed 2019 Feb 11]. https://globalbiodefense.com/2013/07/30/wellcome-trust-to-finance-development-of-shigella-vaccine/.
   Google Scholar
• The European & Developing Countries Clinical Trials Partnership (EDCTP). Vaccines for diarrhoeal diseases or lower respiratory tract infections: Research and Innovation Action (RIA) call budget [Internet]; [accessed 2018 Dec 10]. http://www.edctp.org/call/vaccines-for-diarrhoeal-diseases-or-lower-respiratory-tract-infections/.
   Google Scholar
• PATH. Diarrheal disease [Internet]; [accessed 2018 Dec 10]. https://www.path.org/diarrheal-disease/.
   Google Scholar
• Kotloff KL, Riddle MS, Platts-Mills JA, Pavlinac P, Zaidi AKM. Shigellosis. Lancet. 2017;17:33296–98. doi:https://doi.org/10.1016/S1473-3099(17)30242-6.
   Google Scholar
• Williams PCM, Berkley JA. Paediatrics and International Child Health Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence. Paediatr Int Child Health. 2018;9047:1–16.
   Google Scholar
• Chen WH, Kotloff L, Riddle MS, Kaminski RW, Di Paolo C, Porter CK, Gutierrez RL, Immu CV. Shigella vaccine development: finding the path of least resistance. Clin Vaccine Immunol. 2016;23:904–07.
   Google Scholar
• Lipsitch M, Siber GR. How can vaccines contribute to solving the antimicrobial resistance problem? MBio. 2016;7:e00428–16. doi:https://doi.org/10.1128/mBio.00428-16.
   PubMed Web of Science ®Google Scholar
• Mounier J, Vasselon T, Hellio R, Lesourd M, Sansonetti PJ. Shigella flexneri enters human colonic Caco-2 epithelial cells through the basolateral pole. Infect Immun. 1992;60:237–48.
   PubMed Web of Science ®Google Scholar
• Sansonetti PJ, Phalipon A. M cells as ports of entry for enteroinvasive pathogens: mechanisms of interaction, consequences for the disease process. Semin Immunol. 1999;11:193–203. doi:https://doi.org/10.1006/smim.1999.0175.
   PubMed Web of Science ®Google Scholar
• Arena ET, Campbell-Valois F-X, Tinevez J-Y, Nigro G, Sachse M, Moya-Nilges M, Nothelfer K, Marteyn B, Shorte SL, Sansonetti PJ. Bioimage analysis of Shigella infection reveals targeting of colonic crypts. Proc Natl Acad Sci. 2015;112:E3282–90. doi:https://doi.org/10.1073/pnas.1509091112.
   PubMed Web of Science ®Google Scholar
• Mathan MM, Mathan VI. Morphology of rectal mucosa of patients with shigellosis. Rev Infect Dis. 1991;13:314–18.
   Google Scholar
• Hilbi H, Moss JE, Hersh D, Chen Y, Arondel J, Banerjee S, Flavell RA, Yuan J, Sansonetti PJ, Zychlinsky A. Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB. J Biol Chem. 1998;273:32895–900. doi:https://doi.org/10.1074/jbc.273.49.32895.
   PubMed Web of Science ®Google Scholar
• Zychlinsky A, Prevost MC, Sansonetti PJ. Shigella flexneri induces apoptosis in infected macrophages. Nature. 1992;358:167–69. doi:https://doi.org/10.1038/358167a0.
   PubMed Web of Science ®Google Scholar
• Arizmendi O, Picking WD, Picking WL. Macrophage apoptosis triggered by IpaD from Shigella flexneri. Infect Immun. 2016;84:1857–65. doi:https://doi.org/10.1128/IAI.01483-15.
   PubMed Web of Science ®Google Scholar
• Sansonetti PJ, Ryter A, Clerc P, Maurelli AT, Mounier J. Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis. Infect Immun. 1986;51:461–69.
   PubMed Web of Science ®Google Scholar
• Goldberg MB, Barzu O, Parsot C, Sansonettil PJ, De Biochimie U. Unipolar localization and ATPase activity of IcsA, a Shigella flexneri protein involved in intracellular movement. J Bacteriol. 1993;175:2189–96.
   Google Scholar
• Bernardini ML, Mounier J, Dwhauteville HNE, Coquis-Rondont M, Sansonetti PJ. Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin. Proc Natl Acad Sci USA. 1989;86:3867–71.
   Google Scholar
• Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003;278:8869–72. doi:https://doi.org/10.1074/jbc.C200651200.
   PubMed Web of Science ®Google Scholar
• Philpott DJ, Yamaoka S, Israel A, Sansonetti PJ. Invasive Shigella flexneri activates NF-κB through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells. J Immunol. 2000;165:903–14. doi:https://doi.org/10.4049/jimmunol.165.2.903.
   PubMed Web of Science ®Google Scholar
• Kasper CA, Sorg I, Schmutz C, Tschon T, Wischnewski H, Kim ML, Arrieumerlou C. Cell-cell propagation of NF-κB transcription factor and MAP kinase activation amplifies innate immunity against bacterial infection. Immunity. 2010;33:804–16. doi:https://doi.org/10.1016/j.immuni.2010.10.015.
   PubMed Web of Science ®Google Scholar
• Lowell GH, MacDermott RP, Summers PL, Reeder AA, Bertovich MJ, Formal SB. Antibody-dependent cell-mediated antibacterial activity: K lymphocytes, monocytes, and granulocytes are effective against Shigella. J Immunol. 1980;125:2778–84.
   PubMed Web of Science ®Google Scholar
• Weinrauch Y, Drujan D, Shapiro SD, Weiss J, Zychlinsky A. Neutrophil elastase targets virulence factors of enterobacteria. Nature. 2002;417:91–94. doi:https://doi.org/10.1038/417091a.
   PubMed Web of Science ®Google Scholar